Pfizer brands now available as generics
Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering codes and list prices.
| Branded Product Name | Generic Product Name | Generic PIP Code | NHS List Price |
| Caverject 10microgram powder and solvent for solution for injection vials (1 vial) | Alprostadil 10microgram powder and solvent for solution for injection vials (1 vial) | 127-8696 | £9.24 |
| Caverject 20microgram powder and solvent for solution for injection vials (1 vial) | Alprostadil 20microgram powder and solvent for solution for injection vials (1 vial) | 127-8688 | £11.94 |
| Dalacin® 2% cream | Clindamycin 2% vaginal cream | 128-3688 | £10.86 |
| Dalacin® T 1% topical lotion (30ml)* | Clindamycin 1% aqueous lotion (30 ml) | 128-3696 | £5.08 |
| Dalacin C 75mg capsules (24 capsules) | Clindamycin 75mg capsules (24 capsules) | 128-0908 | £7.45 |
| Premarin® 0.3mg tablets | Conjugated oestrogens 300microgram tablets | 127-9587 | £24.02 |
| Premarin® 0.625mg tablets | Conjugated oestrogens 625microgram tablets | 127-9579 | £26.87 |
| Premarin® 1.25mg tablets | Conjugated oestrogens 1.25mg tablets | 127-9595 | £52.56 |
| Provera® 2.5mg tablets (30 tablets) | Medroxyprogesterone 2.5mg tablets (30 tablets) | 128-2665 | £1.84 |
| Provera® 5mg tablets (10 tablets)* | Medroxyprogesterone 5mg tablets (10 tablets) | 128-2573 | £1.23 |
| Provera® 10mg tablets (10 tablets) | Medroxyprogesterone 10mg tablets (10 tablets) | 128-2599 | £2.47 |
| Provera® 10mg tablets (90 tablets) | Medroxyprogesterone 10mg tablets (90 tablets) | 128-2680 | £22.15 |
| Provera® 10mg tablets (100 tablets) | Medroxyprogesterone 10mg tablets (100 tablets) | 128-2672 | £24.73 |
| Provera® 100mg tablets (100 tablets)* | Medroxyprogesterone 100mg tablets (100 tablets) | 128-2672 | £49.94 |
| Provera® 200mg tablets (30 tablets) | Medroxyprogesterone 200mg tablets (30 tablets) | 128-2631 | £29.65 |
| Provera® 400mg tablets (30 tablets) | Medroxyprogesterone 400mg tablets (30 tablets) | 128-2649 | £58.67 |
*Table shows Drug Tariff listed pack sizes only – other pack sizes are available
Please note: in most cases, the brand is no longer available to order. Where a prescriber has issued a prescription for an unavailable brand, pharmacy teams are advised to contact the prescriber and request a replacement prescription for the generic equivalent.
For further information please see links below to the commercial information (trade mails) for the Pfizer brands that have transitioned to generics since November 2024.
- UK CP Alprostadil launch trade letter Nov 24
- UK CP Conjugated oestrogen launch trade letter Nov 24
- UK CP Clindamycin caps debranding launch trade letter Jan 2025
- UK CP Medroxprogesterone launch trade letter Feb 25
- UK CP Clindamycin topical lotion debranding launch trade letter Mar 2025
- UK CP Clindamycin vaginal cream generic launch trade letter May 2025
- UK CP Cong oest and mpx launch trade letter May 2025
Premique® Low Dose 0.3mg/1.5mg modified-release tablets is being discontinued in July 2025 with Pfizer launching a generic equivalent. Once stock of the brand is exhausted, branded prescriptions will need to be amended to the generic name ‘Conjugated oestrogens 300microgram / Medroxyprogesterone 1.5mg modified-release tablets’.
Should you require any further information please contact Pfizer Customer Service on 0345 608 8866 or Freephone 0800 032 7907 or if you have any questions relating to the generic medicines listed above.
